These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35570052)

  • 1. Comparison of a novel lateral-flow device to galactomannan assay at different time periods for detections of invasive aspergillosis.
    Hsiao HH; Liu YC; Wang HC; Du JS; Tang SH; Yeh TJ; Hsieh CY; Gau YC; Ke YL; Chuang TM; Hsiao CE; Yen CH; Cho SF; Hsiao SY; Chiou SS; Lin SY; Hsu CM; Lu PL
    J Formos Med Assoc; 2022 Oct; 121(10):2123-2129. PubMed ID: 35570052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Aspergillus galactomannan Ag VIRCLIA® Monotest and the sõna Aspergillus galactomannan lateral flow assay show comparable performance for the diagnosis of invasive aspergillosis.
    Küpper C; Erb TM; Träger J; Meintker L; Valenza G; Bogdan C; Held J
    Mycoses; 2024 Aug; 67(8):e13782. PubMed ID: 39109555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The performance of galactomannan in combination with 1,3-β-D-glucan or aspergillus-lateral flow device for the diagnosis of invasive aspergillosis: Evidences from 13 studies.
    Zhang L; Guo Z; Xie S; Zhou J; Chen G; Feng J; Huang Y
    Diagn Microbiol Infect Dis; 2019 Jan; 93(1):44-53. PubMed ID: 30279025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Efficacy of Aspergillus Galactomannan Lateral Flow Assay in Patients with Hematological Malignancies: A Prospective Multicenter Study.
    Alhan O; Saba R; Akalin EH; Ener B; Ture Yuce Z; Deveci B; Guncu MM; Kahveci HN; Yilmaz AF; Odabasi Z
    Mycopathologia; 2023 Oct; 188(5):643-653. PubMed ID: 37273172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study.
    Hoenigl M; Egger M; Boyer J; Schulz E; Prattes J; Jenks JD
    Mycoses; 2021 Oct; 64(10):1197-1202. PubMed ID: 34252244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Hoenigl M; Prattes J; Spiess B; Wagner J; Prueller F; Raggam RB; Posch V; Duettmann W; Hoenigl K; Wölfler A; Koidl C; Buzina W; Reinwald M; Thornton CR; Krause R; Buchheidt D
    J Clin Microbiol; 2014 Jun; 52(6):2039-45. PubMed ID: 24671798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of lateral flow device and galactomannan for the detection of Aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosis.
    Miceli MH; Goggins MI; Chander P; Sekaran AK; Kizy AE; Samuel L; Jiang H; Thornton CR; Ramesh M; Alangaden G
    Mycoses; 2015 Jun; 58(6):368-74. PubMed ID: 25996144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis.
    White PL; Parr C; Thornton C; Barnes RA
    J Clin Microbiol; 2013 May; 51(5):1510-6. PubMed ID: 23486712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a Novel
    Dichtl K; Seybold U; Ormanns S; Horns H; Wagener J
    J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 31018980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a novel Aspergillus lateral-flow device and the Platelia® galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation.
    Held J; Schmidt T; Thornton CR; Kotter E; Bertz H
    Infection; 2013 Dec; 41(6):1163-9. PubMed ID: 23661288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients.
    Castillo CG; Kauffman CA; Zhai J; Jiang H; Agozino SM; Miceli MH
    Mycoses; 2018 Jan; 61(1):4-10. PubMed ID: 28905439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the JF5-Based Galactomannoprotein EIA Compared to the Lateral Flow Device and the Galactomannan EIA in Serum and Bronchoalveolar Lavage Fluid.
    Aerts R; Mercier T; Houben E; Schauwvlieghe A; Lagrou K; Maertens J
    J Clin Microbiol; 2022 Nov; 60(11):e0094822. PubMed ID: 36214562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of serum galactomannan antigen for detection of invasive aspergillosis in hematological patients].
    Xie LP; Liu T; Meng WT; Zhou J
    Zhonghua Nei Ke Za Zhi; 2006 Dec; 45(12):992-5. PubMed ID: 17326997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Galactomannan Antigen, Beta-d-Glucan, and
    Metan G; Keklik M; Dinç G; Pala Ç; Yıldırım A; Saraymen B; Köker MY; Kaynar L; Eser B; Çetin M
    Indian J Hematol Blood Transfus; 2017 Mar; 33(1):87-92. PubMed ID: 28194062
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of two lateral flow assays in BAL fluids for the detection of invasive pulmonary aspergillosis: A retrospective two-centre study.
    Scharmann U; Verhasselt HL; Kirchhoff L; Buer J; Rath PM; Steinmann J; Ziegler K
    Mycoses; 2020 Dec; 63(12):1362-1367. PubMed ID: 32885514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.
    Sulahian A; Porcher R; Bergeron A; Touratier S; Raffoux E; Menotti J; Derouin F; Ribaud P
    J Clin Microbiol; 2014 Jul; 52(7):2328-33. PubMed ID: 24740084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Evaluation of the Performance of the IMMY
    White PL; Price JS; Posso R; Vale L; Backx M
    J Clin Microbiol; 2020 Nov; 58(12):. PubMed ID: 32967903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the JF5-based Aspergillus galactomannoprotein lateral flow device for diagnosing invasive aspergillosis in cancer patients.
    Wan L; Cai X; Ling M; Kan J; Yin M; Wang H
    Eur J Clin Microbiol Infect Dis; 2024 Jun; 43(6):1221-1229. PubMed ID: 38625450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
    Jung J; Kim MY; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.